Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Ann N Y Acad Sci. 2020 Jul;1471(1):5-17. doi: 10.1111/nyas.13998. Epub 2019 Jan 8.
Cerebral small-vessel disease (cSVD) is a common cause of stroke, functional decline, vascular cognitive impairment, and dementia. Pathological processes in the brain's microcirculation are tightly interwoven with pathology in the brain parenchyma, and this interaction has been conceptualized as the neurovascular unit (NVU). Despite intensive research efforts to decipher the NVU's structure and function to date, molecular mechanisms underlying cSVD remain poorly understood, which hampers the development of cSVD-specific therapies. Important steps forward in understanding the disease mechanisms underlying cSVD have been made using genetic approaches in studies of both monogenic and sporadic SVD. We provide an overview of the NVU's structure and function, the implications for cSVD, and the underlying molecular mechanisms of dysfunction that have emerged from recent genetic studies of both monogenic and sporadic diseases of the small cerebral vasculature.
脑小血管病(cSVD)是中风、功能下降、血管性认知障碍和痴呆的常见原因。大脑微循环的病理过程与脑实质的病理紧密交织在一起,这种相互作用被概念化为神经血管单元(NVU)。尽管迄今为止已经进行了大量研究来阐明 NVU 的结构和功能,但 cSVD 的分子机制仍知之甚少,这阻碍了 cSVD 特异性疗法的发展。使用单基因和散发性 SVD 研究中的遗传方法,在理解 cSVD 发病机制方面取得了重要进展。我们提供了 NVU 的结构和功能概述,对 cSVD 的影响,以及单基因和散发性小脑血管疾病的遗传研究中出现的功能障碍的潜在分子机制。